Clinical efficacy of anastomotic reinforcement suture in preventing anastomotic leakage after rectal cancer surgery: a systematic review and meta-analysis

Author:

Zhang Tao,Wang Gang,Qiu Lei,Lu Feng,Fang Guida,Yin Kaihong,Miao Yongchang

Abstract

Abstract Background and objectives: Anastomotic leakage (AL) is a common postoperative complication of rectal cancer, and the reinforced efficacy of the suture is still contentious. This study aimed to investigate the safety and effectiveness of anastomotic reinforcement suture in the prevention of anastomotic leakage after rectal cancer surgery using the Meta method. Methods: We searched eight major databases (PubMed, Embase, Cochrane Library, Sinomed, Web of Science, Wanfang, VIP, and CNKI) in July 2022 to perform a meta-analysis to evaluate the efficacy of anastomotic reinforcement suture after rectal cancer surgery. The primary outcome measures were anastomotic leakage rate, anastomotic bleeding rate, and infection rate. Results: A total of 10 articles and 1573 subjects were included in the study, including 754 cases in the reinforced suture group and 819 cases in the unreinforced suture group. The results showed that compared to the unreinforced suture, the incidence of anastomotic leakage was less (OR = 0.27, 95% CI 0.17-0.41, P < 0.001) and the incidence of infection was less (OR = 0.43, 95% CI 0.21-0.88, P < 0.05), shorter hospital stay (MD = -0.57, 95% CI -1.15-0.00, P≤0.05), earlier anal exhaust time (MD = -0.3, 95% CI -0.23--0.03, P < 0.05). The operative time (MD = 18.79, 95% CI: 13.57-24.01, P < 0.001) was higher than that of the unreinforced suture group. There were no significant differences in intraoperative blood loss (MD = 0.45, 95% CI -6.96-7.87, P > 0.05), incidence of anastomotic bleeding (OR = 0.44, 95% CI 0.13-1.44, P > 0.05), and incidence rates of intestinal obstruction (OR = 0.71, 95% CI 0.32-1.57, P > 0.05). Conclusions: Existing studies indicate that anastomotic reinforcement suture can significantly reduce the incidence of anastomotic leakage, which has the value of clinical promotion. However, this conclusion still needs multicenter high-quality RCTs with a large sample size to further confirm.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3